, is a world-renowned medical oncologist and physician-scientist known for his advocacy in evidence-based medicine, cancer policy, and global oncology. Currently an Associate Professor at Queen’s University in Canada, he has gained international acclaim for challenging the status quo in cancer care to make treatments more affordable and effective.
- Nepal: He earned his MBBS from the Institute of Medicine, Tribhuvan University, where he graduated with seven gold medals.
- Japan: He moved to Japan as a MEXT scholar to complete his PhD in Medical Oncology at Nagoya University.
- USA: He later completed a post-doctoral fellowship in cancer policy at Harvard Medical School.
- Implementation: Investing in proven, high-value interventions that already exist but are underutilized.
- Affordability: Ensuring that cancer care is accessible in low- and middle-income countries (LMICs) where financial toxicity often prevents treatment.
- Common Sense: He is a co-leader of the Common Sense Oncology movement, which pushes for clinical trials that measure outcomes truly meaningful to patients, such as survival and quality of life, rather than just “surrogate” markers.
- Academic & Global Leadership: Based at Queen’s University, Dr. Gyawali is an Associate Professor of Oncology and Public Health Sciences. He advises the WHO on essential cancer medicines.
- Research Output: He has published over 200 peer-reviewed articles in major journals such as The Lancet Oncology and JAMA Oncology.
- Recognition: He was ranked as the top expert in Global Oncology by ScholarGPS in 2025.
- FASCO: He is the first recipient from Nepal and Queen’s University to be named a Fellow of the American Society of Clinical Oncology (FASCO).
- Distinctions: He received the 2020 ASCO Global Oncology Young Investigator Award and the 2020 Young Health Researcher Award from the Government of Nepal.
- Canadian Honors: He was awarded the 2024/2025 Canadian Cancer Society William E. Rawls Prize.
Discussion about this post